- Home
- RNAC vs WHF Comparison
RNAC vs WHF Comparison
Compare RNAC & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNAC | WHF |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.3M | 164.5M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNAC | WHF |
|---|---|---|
| Price | $6.82 | $7.54 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 2 |
| Target Price | ★ $34.00 | $7.75 |
| AVG Volume (30 Days) | ★ 166.1K | 95.5K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 13.78% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,797,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.35 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.60 | $6.07 |
| 52 Week High | $14.56 | $9.92 |
Technical Indicators
Market Signals| Indicator | RNAC | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 56.61 |
| Support Level | $6.54 | $6.80 |
| Resistance Level | $7.81 | $7.62 |
| Average True Range (ATR) | 0.45 | 0.17 |
| MACD | 0.12 | -0.02 |
| Stochastic Oscillator | 57.01 | 68.31 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.